Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
[31]   CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects [J].
S. A. Ivanova ;
M. L. Filipenko ;
N. M. Vyalova ;
E. N. Voronina ;
I. V. Pozhidaev ;
D. Z. Osmanova ;
M. V. Ivanov ;
O. Yu. Fedorenko ;
A. V. Semke ;
N. A. Bokhan .
Bulletin of Experimental Biology and Medicine, 2016, 160 :687-690
[32]   Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers [J].
Belmonte, Carmen ;
Ochoa, Dolores ;
Roman, Manuel ;
Saiz-Rodriguez, Miriam ;
Wojnicz, Aneta ;
Isabel Gomez-Sanchez, Clara ;
Martin-Vilchez, Samuel ;
Abad-Santos, Francisco .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) :596-605
[33]   A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia [J].
Chavan, Bir S. ;
Kaur, Gurjit ;
Gupta, Deepti ;
Aneja, Jitender .
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (04) :335-342
[34]   Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dys-kinesia in Chinese schizophrenic patients [J].
Yan FU~(1 .
ActaPharmacologicaSinica, 2006, (03) :328-332
[35]   Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials [J].
Gueorguieva, Ivelina ;
Jackson, Kimberley ;
Wrighton, Steven A. ;
Sinha, Vikram P. ;
Chien, Jenny Y. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (04) :523-536
[36]   Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis [J].
Xiao, Tingting ;
Jiao, Bin ;
Zhang, Weiwei ;
Tang, Beisha ;
Shen, Lu .
CNS DRUGS, 2016, 30 (10) :899-907
[37]   Influence of the cytochrome P450 2D6*10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis [J].
Nishimura, Miki ;
Ueda, Mikito ;
Saruwatari, Junji ;
Nakashima, Hiroo ;
Ogusu, Naoki ;
Aoki, Akiko ;
Tsuchimine, Shoko ;
Matsuda, Kazuki ;
Iwashita, Kazuma ;
Ono, Tatsumasa ;
Oniki, Kentaro ;
Shimoda, Kazutaka ;
Yasui-Furukori, Norio .
PHARMACOGENETICS AND GENOMICS, 2016, 26 (09) :403-413
[38]   Impact of gender, albumin, and CYP2C19 polymorphisms on valproic acid in Chinese patients: a population pharmacokinetic model [J].
Guo, Jinlin ;
Huo, Yayu ;
Li, Fang ;
Li, Yuanping ;
Guo, Zhaojun ;
Han, Huaqing ;
Zhou, Yuhong .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
[39]   Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions [J].
Paulzen, Michael ;
Haen, Ekkehard ;
Gruender, Gerhard ;
Lammertz, Sarah E. ;
Stegmann, Benedikt ;
Schruers, Koen R. J. ;
Walther, Sebastian ;
Schoretsanitis, Georgios .
JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (08) :803-809
[40]   Genetic association analysis between CYP2D6*2 allele and tardive dyskinesia in schizophrenic patients [J].
Ohmori, O ;
Kojima, H ;
Shinkai, T ;
Terao, T ;
Suzuki, T ;
Abe, K .
PSYCHIATRY RESEARCH, 1999, 87 (2-3) :239-244
12345